Bidendron antigen nanoarchitectures: Influence of the number of antigenic determinants and antigen size for effector cell activation capacity

被引:0
|
作者
Tesfaye, A. [1 ,2 ]
Benede, S. [3 ]
Morgado, A. [4 ,5 ]
Vida, Y. [4 ,5 ]
Rodriguez-Nogales, A. [2 ,4 ]
Fernandez, T. D. [2 ,6 ]
Paris, J. L. [2 ,4 ]
Jimenez-Sanchez, I. M. [2 ,7 ]
Bogas, G. [2 ,6 ]
Mayorga, C. [2 ,4 ,6 ]
Perez-Inestrosa, E. [4 ,5 ]
Torres, M. J. [2 ,4 ,8 ,9 ]
Montanez, M. [2 ,4 ]
机构
[1] Jimma Univ, Jimma, Ethiopia
[2] Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga, Spain
[3] CSIC UAM, Inst Invest Ciencias Alimentac CIAL, Madrid, Spain
[4] Andalusian Ctr Nanomed & Biotechnol, Malaga, Spain
[5] Univ Malaga, Dept Quim Organ, Malaga, Spain
[6] Hosp Reg Univ Malaga, Allergy Unit, Malaga, Spain
[7] BIONAND, Malaga, Spain
[8] Hosp Reg Univ Malaga, Allergy Unit, Malaga, Spain
[9] Univ Malaga, Dept Med, Fac Med, Malaga, Spain
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
001009
引用
收藏
页码:24 / 25
页数:2
相关论文
共 50 条
  • [1] Aging promotes mast cell activation and antigen presenting capacity in atherosclerosis
    Depuydt, M. A. C.
    Smit, V
    Schaftenaar, F. H.
    Hemme, E.
    Delfos, L.
    Vlaswinkel, F. D.
    Simpson, C.
    Kovanen, P. T.
    Slutter, B.
    Kuiper, J.
    Bot, I
    Foks, A. C.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [2] AGING PROMOTES MAST CELL ACTIVATION AND ANTIGEN PRESENTING CAPACITY IN ATHEROSCLEROSIS
    Depuydt, Marie
    Smit, Virginia
    Schaftenaar, Frank
    Hemme, Esmeralda
    Delfos, Lucie
    Vlaswinkel, Femke
    Simpson, Conor
    Kovanen, Petri
    Slutter, Bram
    Kuiper, Johan
    Bot, Ilze
    Foks, Amanda
    ATHEROSCLEROSIS, 2024, 395
  • [3] CELL ENVELOPES OF PSORIATIC SCALES BEAR ANTIGEN(S) OR ANTIGENIC DETERMINANTS DIFFERENT FROM CALLUS
    QUTAISHAT, SS
    KUMAR, V
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (04) : 600 - 600
  • [4] CELL ENVELOPES OF PSORIATIC SCALES BEAR ANTIGEN(S) OR ANTIGENIC DETERMINANTS DIFFERENT FROM CALLUS
    QUTAISHAT, SS
    KUMAR, V
    CLINICAL RESEARCH, 1988, 36 (03): : A686 - A686
  • [5] S antigen specific effector T cell activation detected by cytokine flow cytometry
    Morgan, JP
    Robins, RA
    Dua, HS
    Tighe, PJ
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (05) : 517 - 520
  • [6] ANTIGENIC REQUIREMENTS FOR T-CELL ACTIVATION - RECONSTITUTION OF A FUNCTIONAL ANTIGEN FROM AN INACTIVE PEPTIDE PORTION OF AN ANTIGEN CONJUGATED TO PROTEIN CARRIERS
    WAN, AM
    LANGTON, BC
    ANDRIA, ML
    BENJAMINI, E
    MOLECULAR IMMUNOLOGY, 1986, 23 (05) : 467 - 474
  • [8] Visualization of effector cell activation within autoimmune CNS lesions after soluble antigen treatment
    Odoardi, F.
    Rune, K.
    Cordiglieri, C.
    Kawakami, N.
    Wekerle, H.
    Fluegel, A.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 158 - 158
  • [9] ANTIGEN PROCESSING REQUIREMENTS FOR T-CELL ACTIVATION - DIFFERENTIAL REQUIREMENTS FOR PRESENTATION OF SOLUBLE CONVENTIONAL ANTIGEN VS CELL-SURFACE MHC DETERMINANTS
    FINNEGAN, A
    NEEDLEMAN, BW
    HODES, RJ
    JOURNAL OF IMMUNOLOGY, 1985, 134 (05): : 2960 - 2965
  • [10] Understanding how antigen mobility and adhesion molecules influence B cell activation
    McArthur, Hannah C. W.
    Bajur, Anna T.
    Iliopoulou, Maro
    Spillane, Katelyn M.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 14A - 14A